Karolinska ATMP Center in focus
At Karolinska’s ATMP Center, innovative treatments for incurable diseases are being developed by modifying gene and tissue cells. Hear from the new Director, Knut Steffensen, and Coordinator, Ewa Ellis, as they explain why ATMP is vital for healthcare and the future.
By modifying gene and tissue cells, new possibilities are emerging to treat diseases that currently lack a cure. We spoke with the new ATMP Director, Knut Steffensen, and coordinator, Ewa Ellis, who share why this groundbreaking field is essential for the future of medicine—and what we can expect moving forward.
Watch the video here!
Click on the image below to see the video. It will open in a new window.
Film: Fredric Möller Eklund.
Similar news
Since 2021, all children in Sweden diagnosed with cancer have been offered precision medicine diagnostics through whole genome sequencing.
Five researchers at Karolinska Institutet receive 30 million SEK from VR to establish a cancer treatment center of excellence. Funding is for 5 years, with potential for 5 more years after evaluation.